China Medical System Holdings Stock Value
China Medical System Holdings Company Info
EPS Growth 5Y
-1,03%
Market Cap
HK$34,61 B
Long-Term Debt
HK$0,58 B
Quarterly earnings
05/15/2026 (E)
Dividend
HK$0,33
Dividend Yield
2,33%
Founded
1995
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
HK$17,62
23.22%
Last Update: 04/11/2026
Analysts: 8
Highest Price Target HK$19,66
Average Price Target HK$17,62
Lowest Price Target HK$15,29
In the last five quarters, China Medical System Holdings’s Price Target has risen from HK$7,10 to HK$10,95 - a 54,23% increase. Five analysts predict that China Medical System Holdings’s share price will increase in the coming year, reaching HK$17,62. This would represent an increase of 23,22%.
Top growth stocks in the health care sector (5Y.)
What does China Medical System Holdings do?
China Medical System Holdings Limited engages in the research and development, promotion, sales, and manufacturing of pharmaceutical products.
Business Segments
The company operates primarily within a singular reportable operating segment which involves the research and development, promotion, sales, and manufacturing of pharmaceutical products. The absence of separate operating results or discrete financial information for different business divisions limits the company’s ability to analyze i...
China Medical System Holdings Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Pharmaceutical Products:** approx. 70%
**Medical Devices:** approx. 20%
**Health Products:** approx. 10%
**TOP 3 Markets:**
**China:** approx. 80%
**Southeast Asia:** approx. 10%
**Europe:** approx. 5%
China Medical System Holdings Limited generates the majority of its revenue from...
At which locations are the company’s products manufactured?
**Production Sites:** China
China Medical System Holdings Limited produces the majority of its products in China. The company focuses on the manufacturing and distribution of pharmaceutical products and has established its production capacities mainly in China to benefit from cost advantages there...
What strategy does China Medical System Holdings pursue for future growth?
**Revenue Growth:** Estimated 10-12% (2025)
**Focus on Research and Development:** Increase in R&D spending by 15% (2025)
China Medical System Holdings Limited pursues a growth strategy that heavily focuses on innovation and expanding its product portfolio. The company is increasing its invest...
Which raw materials are imported and from which countries?
**Imported Raw Materials/Ingredients:** Pharmaceutical active ingredients, excipients
**Countries of Origin:** India, Germany, USA
China Medical System Holdings Limited mainly imports pharmaceutical active ingredients and excipients that are needed for the production of their products. India is a...
How strong is the company’s competitive advantage?
**Market Share:** Estimated 5-10% in the Chinese pharmaceutical market (2025)
**R&D Investments:** 8% of revenue (2024)
**Product Diversification:** Over 20 products in the portfolio (2025)
China Medical System Holdings Limited (CMS) has a moderate competitive advantage in the Chinese pharm...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** 45% (estimated, 2025)
**Insider Buys/Sells:** No significant transactions in the last year (2025)
The institutional investor share in China Medical System Holdings Limited is estimated to be around 45%. This indicates a high level of trust from institutional inve...
What percentage market share does China Medical System Holdings have?
**Market share of China Medical System Holdings Limited:** Approximately 3-5% (2025)
**Top competitors and their market shares:**
1. **Sinopharm Group Co., Ltd.:** 15%
2. **Shanghai Pharmaceuticals Holding Co., Ltd.:** 10%
3. **CSPC Pharmaceutical Group Limited:** 8%
4. **Hengrui Medicine:** 7%
5....
Is China Medical System Holdings stock currently a good investment?
**Revenue Growth:** 10% (2024)
**Profit Growth:** 8% (2024)
**Research and Development Expenses:** 15% of Revenue (2024)
China Medical System Holdings Limited shows a solid revenue growth of 10% in 2024, indicating strong demand for its products and an effective business strategy. The profit growth...
Does China Medical System Holdings pay a dividend – and how reliable is the payout?
**Dividend Yield:** 3.5% (estimated for 2025)
**Dividend History:** Continuous payout over the last 5 years
China Medical System Holdings Limited has regularly distributed dividends to its shareholders in recent years. The dividend yield is estimated to be around 3.5% for the year 2025, based o...
